Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent

BACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) after biodegradable-polymer (BP) everolimus-eluting stent (EES) implantation remains uncertain. METHODS: This study analyzed 793 patients who underwent percutaneous coronary intervention (PCI) with BP-EES in 10 cardiovascular cente...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Yong-Hoon, Park, Gyung-Min, Roh, Jae-Hyung, Her, Sung-Ho, Lim, Seong-Hoon, Kang, Tae Soo, Lee, Seung Jin, Bae, Jang-Whan, Choi, WoongGil, Yang, Yong-Mo, Kim, Junghee, Choi, Yu Jeong, Choi, Si Wan, Lee, Jae-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534716/
https://www.ncbi.nlm.nih.gov/pubmed/36213459
http://dx.doi.org/10.1155/2022/2914385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534716/
https://www.ncbi.nlm.nih.gov/pubmed/36213459
http://dx.doi.org/10.1155/2022/2914385

Ejemplares similares